Concepedia

Author

L. Torti

Mario Negri Institute for Pharmacological Research

Also Known As

L Torti, L. Torti, Laura Torti

14

Publications

348

Citations

9

H-Index

33

Concepts

All Affiliations

Mario Negri Institute for Pharmacological ResearchSapienza University of RomeAston UniversityUniversità Cattolica del Sacro CuoreCatholic University of America
LT

About

L. Torti is an author at Mario Negri Institute for Pharmacological Research specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

7

7

169

2

Biochemistry

3

3

89

3

Natural Sciences

2

2

51

4

Chemistry

1

1

15

5

Immunology

1

1

21

L. Torti

×

9

Publications

324

Citations

9

H-Index

YearCitations

Hereditary thrombocytosis caused by MPLSer505Asn is associated with a high thrombotic risk, splenomegaly and progression to bone marrow fibrosis

Luciana Teofili, Fiorina Giona, L. Torti,

Haematologica

2009

82

A novel heterozygous HIF2AM535I mutation reinforces the role of oxygen sensing pathway disturbances in the pathogenesis of familial erythrocytosis

Maurizio Martini, Luciana Teofili, Tonia Cenci,

Haematologica

2008

73

Sensitive species-specific monitoring of a new triplatinum anti-cancer drug and its potential related compounds in spiked human plasma by cation-exchange HPLC-ICP-MS

V. Vacchina, L. Torti, Cecilia Allievi,

Journal of Analytical Atomic Spectrometry

2003

41

Characterization of cisplatin-glutathione adducts by liquid chromatography-mass spectrometry evidence for their formation in vitro but not in vivo after concomitant administration of cisplatin and glutathione to rats and cancer patients

A. Bernareggi, L. Torti, Roberto Maffei Facino,

Journal of Chromatography B Biomedical Sciences and Applications

1995

38

Pharmacokinetics of VP16-213 in Lewis lung carcinoma bearing mice

Tina Colombo, Massimo Broggini, L. Torti,

Cancer Chemotherapy and Pharmacology

1982

28

Ovarian reticular cell sarcoma of the mouse (M5076) made resistant to cyclophosphamide.

Maurizio D’Incalci, L. Torti, Giovanna Damia,

PubMed

1983

21

Flow-cytometric analysis of DNA distribution after VP16-213 treatment of Lewis lung carcinoma

Eugenio Erba, Paolo Ubezio, Tina Colombo,

Cancer Chemotherapy and Pharmacology

1983

16

Studies of the mode of action of antitumour triazenes and triazines—IV. The metabolism of 1-(4-acetylphenyl)-3,3-dimethyltriazene

P. Farina, Andreas Gescher, John A. Hickman,

Biochemical Pharmacology

1982

15

Metabolism of the anticancer agent 1-(4-acetylphenyl)-3,3-dimethyltriazene

P. Farina, Emilio Benfenati, R. Reginato,

Journal of Mass Spectrometry

1983

10

Page 1